These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28442256)

  • 1. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
    Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities.
    Patil V; Patil SA; Patil R; Bugarin A; Beaman K; Patil SA
    Med Chem; 2019; 15(2):150-161. PubMed ID: 29792154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
    Loa J; Chow P; Zhang K
    Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents.
    Cole AL; Hossain S; Cole AM; Phanstiel O
    Bioorg Med Chem; 2016 Jun; 24(12):2768-76. PubMed ID: 27161874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
    Gibson MZ; Nguyen MA; Zingales SK
    Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
    Kim SY; Lee IS; Moon A
    Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
    Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Activity of Natural and Synthetic Chalcones.
    Constantinescu T; Lungu CN
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterocyclic chalcone analogues as potential anticancer agents.
    Sharma V; Kumar V; Kumar P
    Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
    Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer chalcones: Structural and molecular target perspectives.
    Mahapatra DK; Bharti SK; Asati V
    Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
    Saito Y; Mizokami A; Tsurimoto H; Izumi K; Goto M; Nakagawa-Goto K
    Eur J Med Chem; 2018 Sep; 157():1143-1152. PubMed ID: 30189396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
    Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
    Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
    Mirossay L; Varinská L; Mojžiš J
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prostaglandin E(2) production by synthetic minor prenylated chalcones and flavonoids: synthesis, biological activity, crystal structure, and in silico evaluation.
    Rullah K; Mohd Aluwi MF; Yamin BM; Abdul Bahari MN; Wei LS; Ahmad S; Abas F; Ismail NH; Jantan I; Wai LK
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3826-34. PubMed ID: 25027933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
    Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T
    Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chalcones against the hallmarks of cancer: a mini-review.
    de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
    Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
    Ethiraj KR; Aranjani JM; Khan FR
    Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in therapeutic applications of chalcones.
    Katsori AM; Hadjipavlou-Litina D
    Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Aminochalcones.
    Irfan R; Mousavi S; Alazmi M; Saleem RSZ
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33213087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.